Amneal Pharmaceuticals, Inc. AMRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 38.7%+2.0pp | 36.9%+0.4pp | 36.8%+1.4pp | 37.7%+2.6pp | 36.7%+1.4pp | |
| Operating margin | 14.3%+1.6pp | 13.1%+4.1pp | 12.2%+5.2pp | 13.2%+6.5pp | 12.7%+6.4pp | |
| Net margin | 4%+4.5pp | 2.4%+6.6pp | 0.2%+7.1pp | 0.1%+6.8pp | -0.5%+6.3pp | |
| Free cash flow margin | 7.9%-1.0pp | 8.9%+0.2pp | 9%-0.9pp | 9.9%+1.8pp | 8.9%+1.6pp | |
| Returns | ||||||
| Return on assets | 3.5%+3.9pp | 2%+5.4pp | 0.2%+5.3pp | 0.1%+4.9pp | -0.4%+4.4pp | |
| Return on invested capital | 20.1%+10.7pp | 15.7%+5.2pp | 13.4%+5.9pp | 10.1%+3.2pp | 9.4%+3.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×0.0× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | |
| Inventory turnover | 3×-0.1× | 3.1×+0.2× | 3.1×+0.1× | 3×0.0× | 3.1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×+1.1× | 2.2×+0.8× | 2.1×+0.8× | 1.4×+0.1× | 1.4×-0.3× | |
| Quick ratio | 1.6×+0.7× | 1.5×+0.6× | 1.4×+0.6× | 0.9×+0.1× | 0.8×-0.1× | |
| Cash ratio | 0.3×+0.2× | 0.3×+0.2× | 0.2×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-assets | 0.7×+0.1× | 0.7×0.0× | 0.7×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Per Share | ||||||
| Book value per share | -$0.14+66.0% | -$0.22+38.3% | -$0.34-11.7% | -$0.35-93.0% | -$0.41-95.9% | |
| Valuation | ||||||
| Market capitalization | $3.97B+51.0% | $3.96B+61.4% | $3.14B+22.1% | $2.55B+30.0% | $2.63B+40.4% | |
| Enterprise value | $6.34B+33.4% | $6.37B+31.7% | $5.52B+12.7% | $4.65B+7.8% | $4.75B+12.2% | |
| Price / earnings | 32.5×— | 55×— | 532.9×— | 755×— | —— | |
| Price / sales | 1.3×+0.4× | 1.3×+0.4× | 1.1×+0.1× | 0.9×+0.1× | 0.9×+0.2× | |
| EV / sales | 2.1×+0.4× | 2.1×+0.4× | 1.9×+0.1× | 1.6×0.0× | 1.7×0.0× | |
| Free cash flow yield | 6.1%-3.5pp | 6.8%-3.1pp | 8.4%-1.9pp | 11.1%+0.3pp | 9.6%-0.2pp | |
| Earnings yield | 3.1%+3.6pp | 1.8%+6.6pp | 0.2%+7.3pp | 0.1%+9.0pp | -0.5%+8.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s profit margins?
- Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
- Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
